Division of Trauma, Emergency Surgery, and Surgical Critical Care, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
J Trauma Acute Care Surg. 2013 Jun;74(6):1462-7. doi: 10.1097/TA.0b013e31828da937.
Intracavitary noncompressible hemorrhage remains a significant cause of preventable death on the battlefield. Two dynamically mixed and percutaneously injected liquids were engineered to create an in situ self-expanding polymer foam to facilitate hemostasis in massive bleeding. We hypothesized that intraperitoneal injection of the polymer could achieve conformal contact with sites of injury and improve survival in swine with lethal hepatoportal injury.
High grade hepatoportal injury was created in a closed abdominal cavity, resulting in massive noncoagulopathic, noncompressible hemorrhage. Animals received either standard battlefield fluid resuscitation (control, n = 12) or fluid resuscitation plus intraperitoneal injection of hemostatic foam (polymer, n = 15) and were monitored for 3 hours. Blood loss was quantified, and all hepatoportal injuries were inspected for consistency.
Before intervention, all animals initially experienced severe, profound hypotension and near-arrest (mean arterial pressure at 10 minutes, 21 [5.3] mm Hg). Overall survival at 3 hours was 73% in the polymer group and 8% in the control group (p = 0.001). Median survival time was more than 150 minutes in the polymer group versus 23 minutes (19-41.5 minutes) in the control group (p < 0.001), and normalized blood loss in the polymer group was 0.47 (0.30) g/kg per minute versus 3.0 (1.3) g/kg per minute in the controls (p = < 0.001). All hepatoportal injuries were anatomically similar, and the polymer had conformal contact with injured tissues.
Intraperitoneal polymer injection during massive noncompressible hemorrhage reduces blood loss and improves survival in a lethal, closed-cavity, hepatoportal injury model. Chronic safety and additional efficacy studies in other models are needed.
体腔内不可压缩性出血仍然是战场上可预防死亡的一个重要原因。两种动态混合并经皮注射的液体被设计用来制造原位自扩张聚合物泡沫,以促进大出血的止血。我们假设,聚合物的腹腔内注射可以与损伤部位达到一致的接触,并提高致命性肝门静脉损伤猪的存活率。
在封闭的腹腔内造成高等级的肝门静脉损伤,导致大量非凝血性、不可压缩性出血。动物接受标准的战场液体复苏(对照组,n = 12)或液体复苏加止血泡沫腹腔内注射(聚合物组,n = 15),并监测 3 小时。定量失血,并检查所有肝门静脉损伤的一致性。
在干预前,所有动物最初都经历了严重的、严重的低血压和近乎停搏(10 分钟时的平均动脉压,21 [5.3]mmHg)。聚合物组的 3 小时总生存率为 73%,对照组为 8%(p = 0.001)。聚合物组的中位生存时间超过 150 分钟,而对照组为 23 分钟(19-41.5 分钟)(p < 0.001),聚合物组的归一化失血量为 0.47(0.30)g/kg/min,而对照组为 3.0(1.3)g/kg/min(p = < 0.001)。所有肝门静脉损伤在解剖上是相似的,聚合物与受损组织有一致的接触。
在大量不可压缩性出血期间,腹腔内聚合物注射可减少失血量并提高致命性、封闭性、肝门静脉损伤模型的存活率。需要进行慢性安全性和其他模型的额外疗效研究。